as on November 5, 2025 at 2:29 am IST
Day's Low
Day's High
2.59%
Downside
5.05%
Upside
52 Week's Low
52 Week's High
90.36%
Downside
17.00%
Upside
Check Ventyx Biosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$608.3M
EPS (TTM)
-1.6617
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-130.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-48.56%
Compare market cap, revenue, PE, and other key metrics of Ventyx Biosciences, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $608.3M | NA | NA | 0.00% | |
| BUY | $39.7B | 455.58% | -16.34 | -264.83% | |
| BUY | $60.2B | 211.18% | 1425.12 | 1.36% | |
| BUY | $109.1B | 98.06% | 30.31 | 31.86% | |
| BUY | $68.5B | 9.39% | 15.62 | 32.13% |
The Ventyx Biosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ventyx Biosciences, Inc. investment value today
Current value as on today
₹3,83,322
Returns
₹2,83,322
(+283.32%)
Returns from Ventyx Biosciences, Inc. Stock
₹2,77,674 (+277.67%)
Dollar Returns*
₹5,648 (+5.65%)
Based on 16 analysts
68.75%
Buy
31.25%
Hold
0.00%
Sell
Based on 16 analysts, 68.75% of analysts recommend a 'BUY' rating for Ventyx Biosciences, Inc.. Average target price of $14.4
Get share price movements and forecasts by analysts on Ventyx Biosciences, Inc..
What analysts predicted
43.61%UPSIDE
Target Price
$14.4
Current Price
$8.12
Analyzed by
16 Analysts
Target
$14.40
Ventyx Biosciences, Inc. target price $14.4, a slight upside of 43.61% compared to current price of $8.12. According to 16 analysts rating.
Investment in Ventyx Biosciences, Inc. Shares on INDmoney has grown by 5925.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:5925.00% versus previous 30 day period
Search interest for Ventyx Biosciences, Inc. Stock has increased by 1020% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1020% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 23 October
Thu, 10:04 AM
-Ventyx shares jumped 86.53% to $7.20 in after-hours trading following positive Phase 2 trial results for VTX3232.
Thu, 02:25 PM
-Ventyx shares surged 55.4% to $6.01 in pre-market after positive Phase 2 study results for VTX3232.
Thu, 11:10 PM
-Ventyx shares surged 93.49% to $7.47 after announcing positive Phase 2 study results for VTX3232.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, VTYX has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 month, VTYX stock has moved up by 128.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 923.2% return, outperforming this stock by 995.0%
| Organisation | Ventyx Biosciences, Inc. |
| Headquarters | 12790 El Camino Real, San Diego, CA, United States, 92130 |
| Industry | Services |
| CEO | Dr. Raju S. Mohan Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Kathy Ogilvie Ph.D. | Senior VP of Translational & Nonclinical Research |
Dr. Sheila K. Gujrathi M.D. | Executive Chairperson |
Dr. Mark S. Forman M.D., Ph.D. | Chief Medical Officer |
Mr. Roy M. Gonzales CPA, M.B.A. | Senior VP of Finance and Principal Financial & Accounting Officer |
Dr. John M. Nuss Ph.D. | Chief Scientific Officer |
Ms. Snehal Naik Ph.D. | Senior VP of Clinical Development |
Ms. Rosa Ferrao | Senior VP of Regulatory Affairs |
Dr. Raju S. Mohan Ph.D. | Founder, CEO, President & Director |
Mr. Matthew Richard Moore | Chief Operating Officer |
Ventyx Biosciences, Inc. share price today is $8.12 as on at the close of the market. Ventyx Biosciences, Inc. share today touched a day high of $8.53 and a low of $7.91.
Ventyx Biosciences, Inc. share touched a 52 week high of $9.5 on and a 52 week low of $0.78 on . Ventyx Biosciences, Inc. stock price today i.e. is closed at $8.12,which is 14.53% down from its 52 week high and 937.04% up from its 52 week low.
Ventyx Biosciences, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Ventyx Biosciences, Inc. (VTYX) shares with as little as ₹88.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.70 in Ventyx Biosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ventyx Biosciences, Inc. share’s latest price of $8.12 as on November 5, 2025 at 2:29 am IST, you will get 1.2315 shares of Ventyx Biosciences, Inc.. Learn more about
fractional shares .